STOJASPAL, Martin, Tomáš JANOVIČ, Pavel VEVERKA and Ctirad HOFR. DYNAMICS OF REST-TRF2 INTERACTIONS AND THE FATE OF NEURAL CANCER CELLS. Online. In František Foret, Jana Křenková, Iveta Drobníková, Karel Klepárník, Jan Přikryl. 15 th International Interdisciplinary Meeting on Bioanalysis. Brno: Institute of Analytical Chemistry of the CAS, v. v. i., Brno, Czech Republic, 2018, p. 276-282. ISBN 978-80-904959-7-5.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name DYNAMICS OF REST-TRF2 INTERACTIONS AND THE FATE OF NEURAL CANCER CELLS
Authors STOJASPAL, Martin (203 Czech Republic, belonging to the institution), Tomáš JANOVIČ (203 Czech Republic, belonging to the institution), Pavel VEVERKA (203 Czech Republic, belonging to the institution) and Ctirad HOFR (203 Czech Republic, guarantor, belonging to the institution).
Edition Brno, 15 th International Interdisciplinary Meeting on Bioanalysis, p. 276-282, 7 pp. 2018.
Publisher Institute of Analytical Chemistry of the CAS, v. v. i., Brno, Czech Republic
Other information
Original language English
Type of outcome Proceedings paper
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Publication form electronic version available online
RIV identification code RIV/00216224:14740/18:00106746
Organization unit Central European Institute of Technology
ISBN 978-80-904959-7-5
Keywords in English REST-TRF2 INTERACTIONS; NEURAL CANCER CELLS
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 2/4/2019 12:52.
Abstract
Glioblastomas (GBM) are the most frequent brain tumors in adults. No efficient treatment of GMB has been developed so far. The median maximum survival rate of glioblastoma-suffering patients is 12 months. The Repressor Element-1 Silencing Transcription factor (REST), also known as Neuron-Restrictive Silencing Factor (NRSF) is a transcriptional repressor recognized as a negative regulator of many genes, mainly neuronal. REST is usually expressed in nonneuronal tissues and stem cells, wherein it suppresses neuronal differentiation. REST is also present in differentiated neurons during the postnatal brain development and in normal aging, where it promotes neuroprotection by repressing genes involved in oxidative stress. But what makes REST so interesting? REST is crucial for self-renewal of cancer stem cell and brain tumor cells such as GBM. Shelterin protein TRF2 protects REST against proteasomal degradation, facilitates the physiological self-renewal of neural progenitor cells and the pathological uncontrolled proliferation of cancer cells. Identification of the interacting regions and following disruption of TRF2-REST interaction targets REST for proteasomal degradation. This could be the way how we can inhibit cancer stem cells and whole GLM tumor proliferation. In our initial studies we used FLIM-FRET (Fluorescence Lifetime Imaging Microscopy – Fluorescence Resonance Energy Transfer), PLA (proximity ligation assay) and pull-down assay to determine interacting regions of REST and TRF2.
Links
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 30/4/2024 23:26